[Collection of peripheral blood stem cells from ABO incompatible allogeneic donors by using blood cell separator].
To evaluate the yield of the blood cell separator for collection of peripheral blood stem cells (PBSC) from ABO major and (or) minor incompatible allogeneic donors and the feasibility of PBSC component infusion to the recipients without removal of erythrocytes or plasma, the Cobe Spectra (Version 6.1) blood cell separator was utilized to collect PBSC component from 9 allogeneic donors. Of all the donors, 4 were ABO major incompatible, 2 were minor incompatible and the other 3 were both major and minor incompatible to corresponding recipients. In each cycle, different amount of PBSC component was harvested, and the variable volume plasma chased the cells into the bag was adjusted according to the ABO incompatibility. The nucleated cell count, percentage of mononuclear cell, number of CD34(+) cell and percentage of viable cell (trypan blue excluding rate) in the component were detected. At the time of infusion, a series of protective measures to the renal function of recipients were taken. The results showed that apheresis was twice performed on these eight donors to collected enough PBSC for transplantation or cryopreservation, except one apheresis was enough for cell amount needed by transplantation, as the donor's body weight was much heavier than that of the recipient. Altogether 17 apheresises were performed, the mean yield of nucleated cells was 3.77 x 10(10), in which 97% to 99% were mononuclear cells (MNC). The harvested number of CD34(+) cell was 8.62 x 10(6)/kg. All the trypan blue exclusion rate was 100%. In ABO major incompatible or both major and minor incompatible component, there were 8 - 10 ml packed erythrocytes; in ABO minor incompatible component, there were 80 - 120 ml of plasma. These components were infused into the recipients without removal of erythrocytes or plasma and no haemolytic reaction was observed in any recipient, and their hematopoietic functions soon recovered. Results suggest that enough PBSC can be acquired by using blood cell separator Cobe Spectra (Version 6.1), with the modified separation factors, and the collected PBSC component can be safely infused into the ABO incompatible recipients without removal of erythrocytes or plasma.
Ma
Shu-Xuan
SX
Department of Blood Transfusion, General Hospital of PLA, Beijing 100853, China. msx66301@tom.com
Liu
Jing-Han
JH
Li
Xi-Jin
XJ
Wang
Tie-Jun
TJ
Ouyang
Xi-Lin
XL
Bai
Li-Xia
LX
Gao
Chun-Ji
CJ
Zhu
Hai-Yan
HY
D000017:ABO Blood-Group System; D018952:Antigens, CD34 / Q000097:blood; D001781:Blood Component Removal / Q000379:methods; D001782:Blood Donors; D001787:Blood Group Incompatibility / Q000097:blood*; D002469:Cell Separation / Q000295:instrumentation*; D002470:Cell Survival; D019650:Hematopoietic Stem Cell Mobilization; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000276:immunology; D006801:Humans; D036102:Peripheral Blood Stem Cell Transplantation / Q000379:methods; D014184:Transplantation, Homologous
D000017:ABO Blood-Group System; D018952:Antigens, CD34